Increased IL-1β levels in tumors and serum are associated with increased tumor grade and enhanced invasion in several cancers, including breast cancer, and are correlated with poor prognosis [11,12,13,14,15,16]. The gene discussed is IL1B; the disease is breast carcinoma.